AngioDynamics Port Catheter Lawsuit (MDL-3125) — Eligibility, Settlement Updates, and How to File

Angiodynamics port catheter lawsuit claims continue to grow in 2026. Hundreds of patients allege that defective port catheters caused serious injuries. These implantable devices deliver chemotherapy and other medications directly into the bloodstream. However, lawsuits claim that excessive barium sulfate in the catheter tubing led to fractures, infections, and dangerous complications. The federal litigation is now consolidated in the Southern District of California. If you or a loved one suffered complications from an AngioDynamics port catheter, you may qualify to seek compensation.

Case Timeline

Last checked: September 03, 2026

Advertisement

  • August 04, 2026 (Bellwether Date): Court-ordered deadline for each side to select nine cases (18 total) for the MDL 3125 bellwether discovery pool, following Judge Ohta’s April 24, 2026 order granting a 60-day extension. (Court Record)
  • July 10, 2026 (Bellwether Date): Judge Jinsook Ohta granted a 60-day extension giving each side until August 4, 2026 to select nine cases each for an initial pool of 18 bellwether claims, with first trials not expected until early 2028. (Court Record)
  • July 10, 2026 (Ruling): The court extended the bellwether schedule, setting fact sheets for July 2026, preliminary discovery by January 2027, and narrowing the pool to eight cases by December 11, 2026. (Court Record)
  • July 10, 2026 (Case Status): Case count rose from 375 to 391 (adding 16 cases) between May and June 2026, while AngioDynamics’s FY2026 10-Q reports approximately 347 port product liability claims as of February 28, 2026. (Court Record)
  • July 10, 2026 (Settlement): No settlement framework has been announced as of mid-2026; projected individual settlement values are estimated at $50,000–$300,000 pending bellwether outcomes. (Court Record)
  • July 08, 2026 (Ruling): Magistrate Judge Valerie E. Torres entered Case Management Order No. 10 in MDL 3125, setting timelines for resolving discovery disputes over Defendant Profile Forms. (Court Record)
  • July 01, 2026 (Case Status): JPML report shows approximately 401 actions pending in MDL 3125 before Judge Jinsook Ohta in the Southern District of California, up about ten cases from June 2026. (Court Record)
  • July 01, 2026 (Case Status): The JPML’s July 1, 2026 pending-actions report shows approximately 401 cases now pending in MDL 3125 before Judge Jinsook Ohta in the Southern District of California, up from roughly 300 in January 2026. (Court Record)
  • June 26, 2026 (Bellwether Date): Court granted a 60-day extension requiring each side to submit nine representative bellwether cases by August 4, 2026, narrowing to four each by December 11, 2026 for a final group of eight trial claims. (Court Record)
  • June 26, 2026 (Bellwether Date): Revised schedule sets fact sheets in July 2026, preliminary discovery by January 2027, and further narrowing in early 2027, pushing the first bellwether trial to no earlier than 2028. (Court Record)
  • What Is the AngioDynamics Port Catheter Lawsuit About?

    Port catheters are small medical devices implanted under the skin. They provide long-term venous access for chemotherapy, antibiotics, and blood draws. AngioDynamics manufactured several popular models. These include the SmartPort, Vortex Port, BioFlo, and Xcela Plus. Navilyst Medical, a subsidiary, also produced the PowerPort device.

    The core allegation in the angiodynamics port catheter lawsuit is a design defect. Barium sulfate is added to catheter tubing to make it visible on X-rays. However, plaintiffs claim AngioDynamics used excessive amounts of this compound. As a result, the polyurethane tubing becomes brittle and prone to cracking. Micro-fractures can allow bacteria to enter the bloodstream. Broken catheter fragments can migrate to the heart or lungs.

    Reported injuries include catheter fracture and fragment migration. Patients have suffered bloodstream infections, sepsis, and deep vein thrombosis. Some required emergency surgery to remove catheter fragments from the heart. In the most severe cases, these complications have resulted in wrongful death. The FDA issued a Class I recall of certain SmartPort kits in February 2021. A second recall of the Vortex MP Port followed in September 2022.

    MDL Case Status and Key Facts

    MDL Detail Current Data
    MDL Number MDL-3125
    Pending Cases 401
    Presiding Judge Jinsook Ohta
    Federal District CAS
    Data Source U.S. Judicial Panel on Multidistrict Litigation
    Last Updated August 03, 2026

    Detail Information
    MDL Number 3125
    Full Case Name In Re: AngioDynamics, Inc., and Navilyst Medical, Inc., Port Catheter Products Liability Litigation
    Presiding Judge Judge Jinsook Ohta
    Federal District Southern District of California
    Approximate Case Count 300+
    MDL Created October 2024
    Bellwether Pool Selection August 2026
    First Bellwether Trial (Est.) Mid-2028

    The U.S. Judicial Panel on Multidistrict Litigation created MDL-3125 in October 2024. All federal angiodynamics port catheter lawsuit cases were transferred to San Diego. Judge Jinsook Ohta oversees all coordinated pretrial proceedings. As of early 2026, more than 300 cases are pending in the MDL. New lawsuits continue to be filed directly into the consolidated proceeding.

    The bellwether selection process is now underway. Each side will choose nine cases for an initial pool of 18. These selections are due by August 2026. Four cases from each side must involve infection claims. Two must involve thrombosis injuries, and two must involve catheter fracture. By February 2027, the pool will narrow to 10 cases. The first bellwether trials are expected to begin in mid-2028.

    Who Qualifies for the AngioDynamics Port Catheter Lawsuit?

    You may qualify for the angiodynamics port catheter lawsuit if you received an AngioDynamics port device and experienced complications. Qualifying devices include the SmartPort, Vortex Port, BioFlo, Xcela Plus, and Navilyst PowerPort. In most cases, patients who suffered injuries after implantation may be eligible to file a claim.

    Common qualifying injuries include catheter fracture or fragmentation. Bloodstream infections and sepsis also qualify. Deep vein thrombosis, pulmonary embolism, and cardiac complications are frequently cited. Patients who required surgical removal of a fractured catheter may have strong claims. Family members of patients who died from complications might be eligible for wrongful death claims.

    To pursue an angiodynamics port catheter lawsuit claim, you will need medical records. These should document the type of port implanted and the injuries you experienced. Evidence that the device malfunctioned strengthens a claim. Typically, you must file within your state’s statute of limitations. This ranges from one to three years from injury discovery in most states. Consulting a licensed attorney early is strongly recommended.

    How to File an AngioDynamics Port Catheter Lawsuit Claim

    The first step is to consult with an experienced mass tort attorney. Many law firms offer free case evaluations for port catheter claims. An attorney can review your medical records and determine if you have a viable case. For example, they will assess whether your specific device and injuries meet the criteria for MDL-3125.

    If your case qualifies, your attorney will file the lawsuit in federal court. New angiodynamics port catheter lawsuit cases can now be filed directly into the MDL in San Diego. Your lawyer will complete a plaintiff fact sheet. This detailed document outlines your medical history, device information, and injuries. It is a critical part of the discovery process in multidistrict litigation.

    Statute of limitations deadlines vary by state. In most cases, the clock starts when you discover the injury. However, some states apply different rules for medical device claims. An attorney familiar with the angiodynamics port catheter lawsuit can help you understand your state’s requirements. Do not delay in seeking legal advice. Missing a filing deadline could permanently bar your claim.

    📨 Get Free Mass Tort Guides Alerts

    Free · No spam · Unsubscribe anytime

    Settlement Updates and What to Expect

    As of May 2026, no global settlement has been announced in MDL-3125. The litigation is still in its early stages. Bellwether case selection is currently underway. These test trials will help both sides evaluate the strength of claims. Settlement negotiations typically begin after bellwether trial results are known.

    The timeline for resolution in the angiodynamics port catheter lawsuit will likely extend into 2028 and beyond. First bellwether trials are not expected until mid-2028. However, individual settlements can sometimes occur before trial. The value of each case depends on several factors. Injury severity, medical expenses, and strength of evidence all play a role.

    Settlement amounts in mass tort cases vary widely. Cases involving wrongful death or emergency surgery typically command higher values. Claims involving infection alone may settle for different amounts. As a result, it is impossible to predict exact figures at this stage. Patients should work closely with their legal team to understand what their individual case may be worth.

    State-by-State Considerations

    Although the angiodynamics port catheter lawsuit is consolidated in federal court in California, state laws still matter. Each plaintiff’s claims are governed by the tort laws of their home state. This affects statutes of limitations, damage caps, and available theories of liability. For example, some states cap non-economic damages in product liability cases.

    States with notable plaintiff counts in port catheter litigation include California, Texas, Florida, New York, and Pennsylvania. Tort reform laws in Texas and Florida may limit certain damage awards. However, states like California and New York generally allow broader recovery. Plaintiffs should review state-specific tort reform guides to understand how local laws affect their case.

    Frequently Asked Questions

    What AngioDynamics port catheter models are included in the lawsuit?

    The angiodynamics port catheter lawsuit includes the SmartPort, Vortex Port, BioFlo, Xcela Plus, and Navilyst PowerPort. All of these devices are alleged to contain excessive barium sulfate. This manufacturing defect may cause the catheter to fracture or degrade, leading to serious medical complications.

    How long will the AngioDynamics port catheter MDL take to resolve?

    MDL-3125 is still in early stages as of 2026. Bellwether trials are expected to begin in mid-2028. A global settlement, if reached, could follow after initial trial results. However, mass tort litigation often takes several years from start to finish.

    Can I still file an angiodynamics port catheter lawsuit in 2026?

    Yes, new cases are still being accepted into MDL-3125. However, you must file within your state’s statute of limitations. This is typically two to three years from when you discovered the injury. Contact a licensed attorney as soon as possible to protect your rights.

    Check If You May Qualify

    Mass tort eligibility depends on your specific exposure, injuries, and the state where you live. A licensed mass tort attorney can evaluate your situation at no upfront cost — most work on contingency, meaning you pay nothing unless you recover compensation.

    Official Sources & Resources

    For verified mass tort and MDL information:

    Content last reviewed May 2026. This is general educational information, not legal advice. If you notice outdated information, please contact us.

    Related Guides

    Going through divorce too? Compare state laws at Divorce Help Guide. Affected by a recalled drug as a Medicare patient? See Medicare Cover Guide. Just diagnosed with a serious illness? Compare life insurance at Life Insure Guide. PFAS in your water? Check homeowners coverage at Home Insure Guide.